verse classes of fungi, including the yeast Candida albicans and mold Aspergillus fumigatus, in the face of several classes of antifungal drugs, including azoles and echinochidans.
Hsp90 inhibitors are well tolerated in humans and are currently in clinical trials as antineoplastic agents. However, in mice these drugs have detrimental effects in the context of infection by nonselectively inhibiting mammalian Hsp90, which impairs immune response. Cowen and her colleagues are in the process of screening for fungal-selective inhibitors, and have identifıed some leads that may be applicable in the clinical setting.
Alternatively, Cowen suggests targeting the downstream effector calcineurin. Calcineurin is regulated by KDACs, which deacetylate key lysine residues to enable functional conformation. Cowen has found that inhibiting KDACs is just as effective as inhibiting Hsp90 itself in both in vitro and in vivo studies examining antifungal drug resistance, biofılms, and host survival. KDAC inhibitors are approved for use in humans against leukemia and are in clinical trials for the treatment of other cancers; however, here too it will be important to identify fungal-selective agents. "The divergence of KDACs between fungi and humans is far greater than that for Hsp90, suggesting this might provide a more attractive strategy for antifungal therapy," says Cowen.
"Ideally, a new therapeutic strategy for fungal infectious disease would enhance the effıcacy of existing antifungal drugs, block the emergence of drug resistance, have fungicidal activity, and demonstrate broad effıcacy against diverse fungal pathogens. We have established that harnessing fungal Hsp90 meets all of these criteria and has profound therapeutic benefıts," Cowen concludes.
Shannon Weiman is a freelance writer in San
Francisco, Calif.
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Next-Generation Sequencing Provides Help in Growing "Uncultivable" Microbes John Otrompke
Faster methods of sequencing microbial genomes might hold a key to understanding those microbes well enough to culture some isolates that are considered among the most intractable, according to Joerg Graf of the University of Connecticut in Storrs and his collaborators. He spoke during the 2012 International Symposium on Microbial Ecology (ISME), which convened last August in Copenhagen, Denmark.
"Sometimes these 'unculturable' microbes are in an inactive state, just hanging out in an environment, and some kind of signal has to revive them," Graf says. "Other times, they require specifıc nutrients to allow them to proliferate."
Graf applied this approach to the fırst-time culturing of an as-yet-unnamed microbe that is related to Rikenella, bacteria that are found in the digestive tracts of numerous animal species. "We had an organism we couldn't cultivate, so we used 454 sequencing to see what the organism was like inside the host animal, and then could supply the nutrients it needed to grow," he says, referring to a commercially available DNA sequencing procedure. The host for the Rikenella-like microbe is Hirudo verbana, a leech that is used in medicine, including to treat tissue grafts.
Metatranscriptomes reveal which genes in the microorganisms are highly expressed at a specifıc time, pointing to some of its critical nutritional preferences, according to Graf and his collaborators, some of whose earlier fındings appear in the April 2011 mBio (doi: 10.1128/mBio.00012-11). During the 2012 ISME, he described how they are using 454 pyrosequencing to profıle the microbial community within the leech gut. "Initially, we were thinking that the bacteria proliferated on something supplied in the leech's blood meal," he says. Instead, the Rikenellalike bacteria grow on host-provided mucin.
"Another reason this procedure can be challenging is because most RNA in bacterial cells is ribosomal RNA, which can be very challenging to remove," Graf continues. "We could sequence 98% of it, but it does not really tell us what the physiology of the unculturable microorganism is like. But with this next-generation technique, we can just sequence through, because we can still sequence the messenger RNA, even though a lot of ribosomal RNA is left in the sample." "This research is signifıcant in several ways," says Angela Douglas of Cornell University in Ithaca, N.Y., who uses similar technologies to study microorganisms that associate with insects. "The 1980s saw a dramatic revolution in microbiology, when people showed you could identify a microorganism by its RNA without culturing it. We learned of a biodiversity we hadn't imagined, and of two different classifı-cations of microorganisms, the bacteria and archaea. It also led to the discovery of enormous viruses with very large genomes. It seems we've gone from the viewpoint that if we can't culture it, we can't study it, to the view where sequencing analysis almost replaces culturing, and now we've come full circle to where sequencing data can enhance our potential to culture an organism."
